Biodexa Pharmaceuticals PLC (NAS:BDRX)
$ 5.02 -0.13 (-2.52%) Market Cap: 2.91 Mil Enterprise Value: -3.04 Mil PE Ratio: 0 PB Ratio: 0.41 GF Score: 46/100

Midatech Pharma PLC Investor Webinar Transcript

Dec 01, 2021 / 07:20PM GMT
Release Date Price: $56000 (-4.11%)
Christopher Williams

I would like to move on to our next presenter, which is Stephen Stamp, the CEO and CFO of Midatech Pharma. If we can get Stephen up on the screen, please, Elisa, that will be great. And there's Stephen. Good evening, Stephen.

Stephen A. Stamp
Midatech Pharma plc - CEO, CFO, Company Secretary & Director

Hi, Chris.

Christopher Williams

Okay. You're connected to your presentation. If you can just make that full screen for us. Excellent. Brilliant. Okay. Well, I'll leave you to go through presentation. I'll join you for questions, Stephen. Thank you.

Stephen A. Stamp
Midatech Pharma plc - CEO, CFO, Company Secretary & Director

Thanks. And thanks, everybody, for joining this evening. I'm Stephen Stamp, CEO and CFO of Midatech Pharma plc. Now I've lost my presentation. Where did it go? Got that. If I may, I'll leave the disclaimer as read and get straight into it.

Midatech is a biotech company. We're focused on drug delivery. I'm going to start off

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot